The Carotenoid-Microbiome Connection: How Plant Pigments Shape Gut Bacterial Communities and Metabolic Health

Introduction

The human gut microbiome has emerged as a critical determinant of health, influencing everything from metabolism and immunity to neurological function and disease susceptibility. Comprising trillions of microorganisms representing thousands of species, this complex ecosystem responds dynamically to dietary inputs, with profound implications for host physiology (Valdes et al., 2018). Among the dietary components that modulate gut microbial composition, carotenoids—the vibrant pigments responsible for the red, orange, and yellow hues in fruits and vegetables—have recently garnered attention for their prebiotic-like properties and ability to reshape intestinal bacterial communities in health-promoting directions.

Carotenoids represent a diverse class of over 600 naturally occurring pigments synthesized by plants, algae, and photosynthetic bacteria. Beyond their well-established roles as provitamin A precursors and antioxidants, emerging evidence suggests that carotenoids exert significant effects on gut microbiota composition and function (Kaulmann & Bohn, 2014). This is particularly relevant in the context of Western dietary patterns characterized by high fat intake, which consistently induce dysbiotic shifts in gut microbial communities—specifically, reductions in beneficial genera such as Bifidobacterium and Lactobacillus, coupled with increases in potentially pathogenic members of Enterobacteriaceae, including Escherichia coli and Enterococcus species (Carmody et al., 2015). Remarkably, carotenoid-rich foods appear capable of counteracting these dysbiotic changes, promoting a microbiome profile associated with improved metabolic health, reduced inflammation, and enhanced intestinal barrier function.

This blog article examines the bidirectional relationship between carotenoids and the gut microbiome, exploring the mechanisms through which these phytochemicals modulate bacterial composition, the metabolic consequences of carotenoid-induced microbial shifts, and the therapeutic potential of carotenoid-rich dietary interventions. We will synthesize evidence from preclinical and clinical studies demonstrating that carotenoid consumption—particularly from whole food sources like acerola fruit—can reverse high-fat diet-induced dysbiosis, restore beneficial bacterial populations, and promote metabolic homeostasis through gut microbiome modulation.

The Gut Microbiome: A Metabolic Organ Responsive to Diet

The human gut microbiome functions as a metabolically active organ, performing essential functions that human cells cannot accomplish independently. These microbial communities ferment indigestible dietary fibers into short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which serve as energy sources for colonocytes, regulate immune function, and influence systemic metabolism (Koh et al., 2016). The composition of gut bacterial communities varies substantially between individuals and responds rapidly to dietary changes, with certain dietary patterns promoting health-associated microbial profiles while others drive dysbiotic states linked to obesity, metabolic syndrome, inflammatory bowel disease, and other pathological conditions.

A healthy gut microbiome is characterized by high diversity, with predominance of Firmicutes and Bacteroidetes phyla, and substantial representation of beneficial genera including Bifidobacterium, Lactobacillus, Akkermansia, and Faecalibacterium (Valdes et al., 2018). These beneficial bacteria produce SCFAs, maintain intestinal barrier integrity, compete with pathogenic organisms, modulate immune responses, and synthesize essential vitamins. In contrast, dysbiotic microbiomes associated with Western dietary patterns exhibit reduced diversity, decreased abundance of SCFA-producing bacteria, and increased representation of pro-inflammatory taxa including members of Enterobacteriaceae family (Carmody et al., 2015).

High-fat diets, particularly those rich in saturated fats, consistently induce dysbiotic microbial shifts across multiple species including humans, mice, and rats. These dietary patterns reduce populations of Bifidobacterium and Lactobacillus—genera with established health-promoting properties including immune modulation, pathogen exclusion, and intestinal barrier enhancement—while simultaneously expanding potentially pathogenic Enterobacteriaceae, E. coli, and Enterococcus populations (Hildebrandt et al., 2009). These microbial changes contribute to metabolic endotoxemia, systemic inflammation, insulin resistance, and adiposity, creating a vicious cycle wherein diet-induced dysbiosis exacerbates metabolic dysfunction. Understanding dietary interventions that can prevent or reverse these dysbiotic shifts represents a critical priority for metabolic health optimization.

Carotenoids: Beyond Antioxidants to Microbiome Modulators

Carotenoids encompass over 600 structurally related compounds, broadly classified into two categories: carotenes (including β-carotene, α-carotene, and lycopene) and xanthophylls (including lutein, zeaxanthin, astaxanthin, and β-cryptoxanthin). While historically studied primarily for their provitamin A activity and antioxidant properties, carotenoids exert diverse biological effects that extend well beyond these classical functions (Kaulmann & Bohn, 2014). Their lipophilic nature allows carotenoids to incorporate into cellular membranes, influence membrane fluidity, modulate cell signaling pathways, and regulate gene expression through nuclear receptor activation.

Recent investigations have revealed that carotenoids can profoundly influence gut microbial composition, though the mechanisms underlying these effects remain incompletely characterized. Several potential mechanisms have been proposed: First, carotenoids may exert selective antimicrobial effects, inhibiting growth of pathogenic bacteria while permitting or promoting growth of beneficial species (Gong et al., 2018). Second, carotenoid metabolism by gut bacteria generates bioactive metabolites that may themselves influence microbial community structure and function. Third, carotenoids may modulate host factors—including bile acid composition, intestinal pH, mucus production, and immune responses—that indirectly shape microbial communities. Finally, carotenoids often co-occur with other bioactive compounds in whole foods, including polyphenols, vitamins, and fiber, which may act synergistically to promote beneficial microbial profiles.

The bioavailability and metabolism of carotenoids depends significantly on gut microbial activity. Intestinal bacteria participate in carotenoid biotransformation, producing various metabolites with distinct biological activities (Nagao, 2014). For instance, bacterial enzymes can cleave carotenoids at positions other than the central 15,15′ bond used by mammalian enzymes, generating eccentric cleavage products with unique bioactivities. Additionally, the efficiency of carotenoid absorption from the intestinal lumen depends on microbial modification of the food matrix, bile acid metabolism, and maintenance of intestinal barrier integrity—all processes influenced by gut bacterial communities. This creates a bidirectional relationship wherein carotenoids shape microbial composition, while microbial communities determine carotenoid bioavailability and metabolism.

High-Fat Diet-Induced Dysbiosis: The Clinical Problem

High-fat diets, particularly those rich in saturated fatty acids typical of Western dietary patterns, consistently induce dysbiotic shifts in gut microbial communities across multiple species and experimental paradigms. These dietary interventions rapidly decrease the abundance of health-promoting bacterial genera including Bifidobacterium and Lactobacillus while simultaneously expanding potentially pathogenic members of the Enterobacteriaceae family, including E. coli and Enterococcus species (Hildebrandt et al., 2009). These changes occur within days of dietary intervention and are associated with metabolic endotoxemia, systemic inflammation, insulin resistance, and adiposity.

Bifidobacterium species, Gram-positive anaerobes that dominate the healthy infant gut and remain important throughout life, perform numerous beneficial functions including SCFA production, vitamin synthesis, competitive exclusion of pathogens, and immune system education (Turroni et al., 2018). These bacteria ferment complex carbohydrates into acetate and lactate, creating an acidic intestinal environment inhospitable to many pathogens. Bifidobacteria also strengthen intestinal barrier function by upregulating tight junction proteins and stimulating mucus production. The reduction in Bifidobacterium abundance associated with high-fat feeding correlates with increased intestinal permeability, metabolic endotoxemia, and systemic inflammation (Cani et al., 2008).

Similarly, Lactobacillus species—diverse Gram-positive bacteria found throughout the gastrointestinal tract—contribute to host health through multiple mechanisms including lactic acid production, pathogen inhibition through bacteriocin secretion, immune modulation, and maintenance of intestinal barrier integrity (Walter, 2008). Lactobacilli produce various antimicrobial compounds that suppress pathogenic bacteria while modulating both innate and adaptive immune responses. The decrease in Lactobacillus populations with high-fat feeding removes these protective functions, permitting expansion of opportunistic pathogens and pro-inflammatory bacterial taxa.

Conversely, high-fat diets promote expansion of Enterobacteriaceae, a family of Gram-negative bacteria that includes numerous pathogens and opportunistic organisms. Enterobacteriaceae possess lipopolysaccharide (LPS) in their outer membrane, a potent endotoxin that triggers systemic inflammation when absorbed into circulation (Cani et al., 2008). Increased Enterobacteriaceae abundance, particularly E. coli and Enterococcus species, correlates with metabolic endotoxemia, insulin resistance, and metabolic syndrome. These organisms thrive in the altered intestinal environment created by high-fat feeding, which includes changes in bile acid composition, reduced SCFA production, increased intestinal pH, and compromised barrier function (Hildebrandt et al., 2009). Breaking this cycle of dysbiosis-driven metabolic dysfunction requires dietary interventions that can restore beneficial bacterial populations while suppressing pathogenic taxa.

Acerola and Carotenoid-Rich Foods: Reversing Dysbiosis

Acerola (Malpighia emarginata), a tropical fruit native to Central and South America, represents one of nature's richest sources of vitamin C, containing 50-100 times more ascorbic acid than oranges by weight. Beyond its exceptional vitamin C content, acerola provides substantial quantities of carotenoids (including β-carotene, β-cryptoxanthin, and other provitamin A carotenoids), polyphenols (particularly anthocyanins and flavonoids), and other bioactive phytochemicals (Prakash & Baskaran, 2018). This unique phytochemical profile positions acerola as an ideal food for investigating how carotenoid-rich whole foods influence gut microbial composition and metabolic health.

Experimental studies have demonstrated that incorporating acerola preparations into high-fat diets can substantially modify gut microbial composition in health-promoting directions. In rodent models, animals consuming high-fat diets supplemented with acerola fruit preparations showed increased activity and abundance of Bifidobacterium and Lactobacillus species in the gastrointestinal tract, coupled with significant reductions in Enterobacteriaceae, E. coli, and Enterococcus populations (Dias et al., 2014). These microbial shifts effectively reversed the dysbiotic profile typically induced by high-fat feeding, restoring a microbiome composition more closely resembling that of animals consuming standard low-fat diets.

The mechanisms underlying acerola's beneficial effects on gut microbiota likely involve multiple components acting synergistically. The high carotenoid content may exert selective antimicrobial effects or serve as substrates for beneficial bacterial metabolism. The abundant polyphenols in acerola can function as prebiotics, selectively promoting growth of beneficial bacteria while inhibiting pathogens (Duda-Chodak et al., 2015). The exceptional vitamin C content may influence intestinal pH and redox status, creating environmental conditions favoring beneficial bacteria. Additionally, the fiber content of whole acerola preparations provides fermentable substrates for SCFA-producing bacteria. Distinguishing the relative contributions of these components requires systematic investigation, though evidence suggests that whole food preparations containing multiple bioactive compounds may be more effective than isolated components due to synergistic interactions.

The restoration of beneficial bacterial populations through acerola supplementation has significant metabolic consequences. Increased Bifidobacterium and Lactobacillus abundance correlates with improved glucose homeostasis, enhanced insulin sensitivity, reduced systemic inflammation, and decreased adiposity even in animals continuing to consume high-fat diets (Everard et al., 2011). These benefits appear mediated partly through increased SCFA production, improved intestinal barrier function, reduced metabolic endotoxemia, and modulation of host metabolism through bacterial-derived metabolites. Thus, carotenoid-rich foods like acerola may represent practical dietary interventions for preventing or reversing diet-induced dysbiosis and its metabolic consequences.

Mechanisms of Carotenoid-Mediated Microbiome Modulation

The mechanisms through which carotenoids influence gut microbial composition involve complex interactions between dietary compounds, bacterial metabolism, and host physiology. Several complementary mechanisms likely operate simultaneously to produce the observed microbial shifts.

Selective Antimicrobial Activity:

Certain carotenoids exhibit selective antimicrobial properties, inhibiting growth of pathogenic bacteria while permitting or enhancing growth of beneficial species. Studies have demonstrated that β-carotene, lycopene, and astaxanthin can inhibit growth of various pathogenic bacteria including E. coli, Staphylococcus aureus, and Salmonella species through mechanisms involving membrane disruption, oxidative stress induction, and interference with bacterial quorum sensing (Gong et al., 2018). Importantly, these antimicrobial effects appear selective, with beneficial bacteria such as Lactobacillus and Bifidobacterium species showing greater resistance to carotenoid-mediated growth inhibition. This selectivity may reflect differences in membrane composition, antioxidant defense systems, or metabolic capacity between beneficial and pathogenic bacteria.

Bacterial Carotenoid Metabolism:

Gut bacteria actively metabolize dietary carotenoids, generating various bioactive metabolites that may influence microbial community structure. Bacterial enzymes can cleave carotenoids at positions distinct from mammalian cleavage sites, producing eccentric cleavage products with unique biological activities (Nagao, 2014). Certain bacterial species, particularly Bifidobacterium and Lactobacillus strains, possess enzymatic machinery for carotenoid biotransformation and may utilize carotenoids or their metabolites as growth substrates or signaling molecules. This metabolic capacity could provide competitive advantages to carotenoid-metabolizing bacteria, explaining their expansion in carotenoid-rich dietary contexts.

Modulation of Host-Derived Factors:

Carotenoids influence multiple host physiological processes that indirectly shape gut microbial communities. Dietary carotenoids modulate bile acid synthesis and composition, with consequences for microbial community structure since bile acids exert selective antimicrobial effects and serve as signaling molecules for both host and bacterial cells (Wahlström et al., 2016). Carotenoids also enhance intestinal barrier function by upregulating tight junction proteins and stimulating mucus production, creating physical barriers that influence bacterial access to the intestinal epithelium (Kim et al., 2018). Additionally, carotenoids modulate immune responses in the gut-associated lymphoid tissue, influencing secretory IgA production and antimicrobial peptide secretion, which selectively shape microbial composition.

Synergistic Effects with Co-Occurring Compounds:

In whole foods, carotenoids co-occur with numerous other bioactive compounds including polyphenols, vitamins, organic acids, and fiber. These components may act synergistically to promote beneficial microbial profiles. For example, the polyphenols abundant in acerola exhibit prebiotic properties, selectively promoting Bifidobacterium and Lactobacillus growth (Duda-Chodak et al., 2015). The vitamin C in acerola may create reducing conditions that favor anaerobic beneficial bacteria while limiting aerotolerant pathogens. The organic acids in fruits acidify intestinal contents, creating environmental conditions favoring acid-tolerant beneficial bacteria over pH-sensitive pathogens. These synergistic interactions likely explain why whole carotenoid-rich foods often show more robust effects on gut microbiota than isolated carotenoid supplements.

Metabolic Consequences of Carotenoid-Induced Microbiome Shifts

The restoration of beneficial bacterial populations and suppression of pathogenic taxa through carotenoid consumption translates into tangible metabolic benefits. These effects operate through multiple interconnected mechanisms linking gut microbiota composition to host metabolic homeostasis.

Enhanced Short-Chain Fatty Acid Production: Bifidobacterium and Lactobacillus species, expanded by carotenoid-rich diets, produce acetate, lactate, and other organic acids through carbohydrate fermentation (Koh et al., 2016). These SCFAs serve multiple beneficial functions: they provide energy substrates for colonocytes, enhance intestinal barrier function, modulate immune responses, regulate appetite through gut hormone secretion, and influence systemic metabolism through G-protein coupled receptor activation. Butyrate, produced by bacteria that utilize lactate generated by Bifidobacterium and Lactobacillus, exhibits particularly potent effects on colonocyte health, barrier function, and anti-inflammatory activity. The increased SCFA production associated with carotenoid-mediated microbiome shifts contributes significantly to improved metabolic outcomes.

Reduced Metabolic Endotoxemia: The reduction in Enterobacteriaceae, E. coli, and Enterococcus populations induced by carotenoid consumption decreases the intestinal burden of LPS-containing Gram-negative bacteria (Cani et al., 2008). Combined with enhanced intestinal barrier function from Bifidobacterium and Lactobacillus abundance, this results in reduced translocation of bacterial LPS into systemic circulation, a phenomenon termed metabolic endotoxemia. Chronic low-grade endotoxemia drives systemic inflammation, insulin resistance, and metabolic dysfunction. By simultaneously reducing LPS-producing bacteria and strengthening intestinal barriers, carotenoid-rich diets interrupt this pathogenic process, reduce inflammation and improve metabolic health.

Improved Glucose Homeostasis and Insulin Sensitivity: Multiple mechanisms link carotenoid-induced microbiome shifts to improved glucose metabolism. Increased SCFA production, particularly propionate, enhances hepatic insulin sensitivity and reduces hepatic glucose production (Koh et al., 2016). Reduced metabolic endotoxemia decreases inflammatory signaling that interferes with insulin receptor function. Enhanced intestinal barrier function reduces the translocation of bacterial metabolites that promote insulin resistance. Additionally, certain bacteria expanded by carotenoid consumption produce metabolites that directly influence host glucose metabolism, including conjugated linoleic acid and various bioactive peptides (Everard et al., 2011). Clinical studies have demonstrated that interventions increasing Bifidobacterium and Lactobacillus abundance improve glycemic control in individuals with metabolic syndrome and type 2 diabetes.

Modulation of Lipid Metabolism and Adiposity: Gut microbiota composition influences host lipid metabolism through multiple pathways including bile acid metabolism, SCFA-mediated signaling, regulation of genes involved in lipogenesis and lipolysis, and modulation of adipose tissue inflammation (Schoeler & Caesar, 2019). The microbiome shifts induced by carotenoid-rich diets—particularly expansion of Akkermansia muciniphila and certain Lactobacillus species—have been associated with reduced adiposity, improved lipid profiles, and decreased hepatic steatosis in both animal models and human studies. These effects appear mediated partly through bacterial production of metabolites that activate host metabolic regulators including AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptors (PPARs).

Carotenoid-Microbiome Interactions Across the Lifespan

The relationship between carotenoid intake and gut microbiota composition may vary across different life stages, with particular significance during critical developmental windows and in aging populations. Understanding these temporal dynamics has important implications for optimizing health outcomes through targeted dietary interventions.

Early Life Programming: The gut microbiome undergoes dramatic compositional changes during infancy and early childhood, with profound implications for immune system development, metabolic programming, and long-term health trajectories (Bäckhed et al., 2015). Breast milk contains significant quantities of carotenoids, including β-carotene, lycopene, and lutein, which may contribute to establishing a healthy infant gut microbiome dominated by Bifidobacterium species. Formula-fed infants typically show reduced Bifidobacterium abundance and increased Enterobacteriaceae compared to breastfed counterparts, though carotenoid fortification of infant formula may partially address this disparity. The introduction of carotenoid-rich complementary foods during weaning represents another critical window for microbiome development, potentially establishing beneficial bacterial populations that persist throughout life.

Adult Metabolic Health: In adults, carotenoid intake correlates with gut microbiome diversity and beneficial bacterial abundance across multiple population studies (Henning et al., 2018). Individuals consuming diets rich in fruits and vegetables—the primary carotenoid sources—consistently show higher microbiome diversity, increased Bifidobacterium and Lactobacillus abundance, and greater representation of SCFA-producing bacteria compared to those consuming Western diets low in plant foods. Intervention studies demonstrate that increasing fruit and vegetable consumption rapidly shifts gut microbial composition toward more beneficial profiles, with corresponding improvements in metabolic markers including glucose tolerance, lipid profiles, and inflammatory biomarkers. These effects appear particularly pronounced in individuals with metabolic syndrome or obesity, suggesting that carotenoid-rich dietary interventions may be especially beneficial for those at highest metabolic risk.

Aging and Microbiome Resilience: Aging is associated with reduced gut microbiome diversity, decreased abundance of beneficial bacteria including Bifidobacterium species, and increased representation of pro-inflammatory taxa (Claesson et al., 2012). These age-related microbiome changes contribute to inflammaging—chronic low-grade inflammation that accelerates age-related diseases and functional decline. Carotenoid intake typically decreases with aging due to reduced fruit and vegetable consumption, potentially exacerbating age-related dysbiosis. Importantly, intervention studies suggest that increasing carotenoid-rich food consumption in elderly populations can partially reverse age-related microbiome changes, increasing beneficial bacterial abundance and reducing inflammatory markers (Claesson et al., 2012). These findings suggest that maintaining adequate carotenoid intake throughout the lifespan, particularly in later years, may support microbiome resilience and healthy aging.

Specific Carotenoids and Differential Microbiome Effects

While most research has examined carotenoid-rich whole foods containing complex mixtures of these compounds, emerging evidence suggests that individual carotenoids may exert distinct effects on gut microbial composition. Understanding these compound-specific effects could inform targeted dietary recommendations and supplement formulations.

β-Carotene: The most abundant provitamin A carotenoid in the human diet, β-carotene has demonstrated prebiotic-like properties in multiple studies. Research indicates that β-carotene supplementation increases Lactobacillus and Bifidobacterium abundance while reducing Enterobacteriaceae populations in both animal models and human trials (Tanumihardjo et al., 2016). These effects appear independent of vitamin A conversion, as supplementation with preformed vitamin A does not produce comparable microbiome shifts. β-Carotene may be metabolized by certain gut bacteria, generating bioactive cleavage products that influence bacterial growth and community structure. Additionally, β-carotene's lipophilic nature allows membrane incorporation, potentially influencing membrane fluidity and bacterial growth dynamics.

Lycopene: Found abundantly in tomatoes and processed tomato products, lycopene exhibits potent antioxidant properties and has been associated with reduced cardiovascular disease and cancer risk. Recent investigations reveal that lycopene consumption influences gut microbiota composition, increasing the abundance of Akkermansia muciniphila—a mucin-degrading bacterium associated with metabolic health—and various Lactobacillus species (Rowles et al., 2017). Lycopene metabolism by gut bacteria generates various bioactive metabolites including apo-lycopenoids, which may themselves influence bacterial growth and host physiology. The microbiome-modulating effects of lycopene may contribute to its established cardiometabolic benefits, though this hypothesis requires further investigation.

Lutein and Zeaxanthin: These xanthophyll carotenoids, concentrated in leafy green vegetables and known for their roles in visual health, also influence gut microbiota composition. Studies have shown that lutein supplementation increases the abundance of butyrate-producing bacteria including Faecalibacterium prausnitzii and reduces pro-inflammatory bacterial taxa (Johnson et al., 2019). These effects may be particularly relevant for inflammatory conditions including inflammatory bowel disease and metabolic syndrome. The hydroxyl groups on lutein and zeaxanthin distinguish them chemically from carotenes, potentially conferring distinct membrane interactions and bacterial metabolism patterns that explain their unique microbiome effects.

Astaxanthin: This marine-derived xanthophyll, found in salmon, shrimp, and algae, exhibits exceptionally potent antioxidant properties. Research has demonstrated that astaxanthin supplementation modulates gut microbiota composition, increasing Lactobacillus and Bifidobacterium while reducing Bacteroides and Clostridium populations in animal models (Zhang et al., 2020). Astaxanthin also enhances intestinal barrier function and reduces inflammation in the gut-associated lymphoid tissue, effects that may be mediated partly through microbiome modulation. The unique molecular structure of astaxanthin, with hydroxyl and keto groups at both ends of the molecule, may confer distinct biological properties relevant to microbiome interactions.

Clinical Applications and Therapeutic Potential

The evidence linking carotenoid consumption to beneficial microbiome shifts has significant clinical implications for preventing and treating various metabolic and inflammatory diseases. Several therapeutic applications warrant particular attention based on current evidence.

Metabolic Syndrome and Type 2 Diabetes: Given the strong associations between gut dysbiosis, metabolic endotoxemia, and insulin resistance, carotenoid-rich dietary interventions represent promising approaches for metabolic disease prevention and management (Schoeler & Caesar, 2019). Clinical trials have demonstrated that increasing fruit and vegetable consumption—the primary dietary carotenoid sources—improves glycemic control, reduces inflammatory markers, and enhances insulin sensitivity in individuals with metabolic syndrome and type 2 diabetes. These metabolic improvements correlate with microbiome shifts toward increased beneficial bacterial abundance and reduced Enterobacteriaceae populations. Incorporating carotenoid-rich foods into dietary interventions for metabolic disease may enhance efficacy through complementary mechanisms involving both direct metabolic effects and microbiome-mediated pathways.

Weight Management: Gut microbiota composition differs substantially between lean and obese individuals, with obesity associated with reduced microbial diversity, decreased Akkermansia and Bifidobacterium abundance, and increased capacity for energy harvest from diet (Turnbaugh et al., 2009). Carotenoid-rich dietary patterns have been inversely associated with obesity risk across multiple population studies, and intervention trials demonstrate that increased fruit and vegetable consumption promotes modest weight loss and prevents weight regain following initial loss. These effects appear mediated partly through microbiome modulation, with carotenoid-induced increases in Akkermansia muciniphila and Lactobacillus species associated with improved metabolic health and reduced adiposity independent of weight loss (Everard et al., 2013). Incorporating abundant carotenoid-rich foods into weight management programs may enhance long-term success through beneficial microbiome effects.

Inflammatory Bowel Disease: Dysbiosis is a hallmark feature of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, with patients showing reduced beneficial bacteria and increased adherent-invasive E. coli and other pathogenic taxa (Frank et al., 2007). The anti-inflammatory properties of carotenoids, combined with their microbiome-modulating effects, suggest potential therapeutic applications in IBD. Preliminary studies indicate that carotenoid supplementation, particularly with lutein and lycopene, may reduce inflammatory markers and disease activity in IBD patients, though large-scale clinical trials are lacking. The microbiome shifts induced by carotenoids—particularly expansion of anti-inflammatory Faecalibacterium prausnitzii and enhancement of intestinal barrier function—may contribute to these beneficial effects.

Cardiovascular Disease Prevention: Gut microbiota metabolism of dietary compounds generates various metabolites that influence cardiovascular health, including trimethylamine N-oxide (TMAO), SCFAs, and secondary bile acids (Tang et al., 2013). Dysbiotic microbiomes with expanded Enterobacteriaceae populations produce higher levels of TMAO and other pro-atherogenic metabolites. Carotenoid-rich dietary patterns have consistently been associated with reduced cardiovascular disease risk, and these benefits may be mediated partly through favorable microbiome modulation. By expanding SCFA-producing bacteria and reducing TMAO-producing taxa, carotenoid consumption may contribute to cardiovascular protection through microbiome-dependent mechanisms complementing their direct antioxidant and anti-inflammatory effects.

Practical Recommendations and Future Directions

Translating the scientific evidence linking carotenoids to beneficial microbiome shifts into practical dietary recommendations requires consideration of food sources, preparation methods, bioavailability factors, and individual variation in microbiome composition and response.

Optimal Food Sources: While carotenoid supplements are available, whole food sources provide carotenoids within complex matrices containing fiber, polyphenols, vitamins, and other bioactive compounds that may act synergistically to promote beneficial microbiome profiles (Kaulmann & Bohn, 2014). Particularly rich carotenoid sources include dark leafy greens (spinach, kale, collards), orange and red vegetables (carrots, sweet potatoes, tomatoes, bell peppers), tropical fruits (mango, papaya, acerola), and certain animal products (salmon, eggs from pasture-raised hens). Consuming diverse carotenoid sources provides varied carotenoid types with potentially complementary microbiome effects.

Preparation and Bioavailability: Carotenoid bioavailability depends significantly on food matrix, preparation method, and co-consumed nutrients. Cooking and mechanical processing disrupt cell walls and food matrices, generally increasing carotenoid bioavailability (Kaulmann & Bohn, 2014). However, excessive heat may degrade certain carotenoids. Co-consumption with dietary fat enhances carotenoid absorption due to their lipophilic nature, suggesting that salad dressings, cooking oils, or fat-containing foods should accompany carotenoid-rich vegetables. Interestingly, the microbiome effects of carotenoids may depend more on total intake reaching the colon than systemic absorption, suggesting that both highly bioavailable and less bioavailable sources may contribute beneficially.

Individual Variation and Personalization: Gut microbiome composition varies substantially between individuals, and this baseline variation likely influences responses to dietary interventions including carotenoid consumption (Valdes et al., 2018). Individuals with severely dysbiotic microbiomes may show more dramatic responses to carotenoid-rich dietary patterns compared to those with already-healthy microbial profiles. Genetic polymorphisms affecting carotenoid metabolism—including variants in the β-carotene cleavage enzyme BCO1—may influence both systemic carotenoid status and gut microbial responses. Future research should explore whether microbiome profiling can identify individuals most likely to benefit from increased carotenoid consumption, enabling personalized dietary recommendations.

Integration with Other Microbiome-Supporting Strategies: Carotenoid consumption should be viewed as one component of a comprehensive dietary pattern supporting gut microbiome health. Fermentable fibers, polyphenols, omega-3 fatty acids, and fermented foods all influence microbiome composition through complementary mechanisms (Valdes et al., 2018). Mediterranean and traditional plant-based dietary patterns, which naturally provide abundant carotenoids alongside these other beneficial components, consistently associate with healthy microbiome profiles and reduced disease risk. Rather than focusing exclusively on individual nutrients, dietary recommendations should emphasize overall patterns featuring diverse plant foods providing carotenoids, fiber, polyphenols, and other bioactive compounds in whole food forms.

Conclusion

The discovery that carotenoids powerfully modulate gut microbial composition represents a paradigm shift in our understanding of how these plant pigments contribute to human health. Far from functioning solely as provitamin A precursors and antioxidants, carotenoids serve as microbiome-modulating compounds that reshape intestinal bacterial communities in health-promoting directions. The ability of carotenoid-rich foods, exemplified by acerola preparations, to reverse high-fat diet-induced dysbiosis—expanding beneficial Bifidobacterium and Lactobacillus populations while suppressing pathogenic Enterobacteriaceae, E. coli, and Enterococcus species—demonstrates the therapeutic potential of dietary interventions targeting the gut microbiome.

These microbiome shifts translate into tangible metabolic benefits including enhanced SCFA production, reduced metabolic endotoxemia, improved glucose homeostasis, and optimized lipid metabolism. The mechanisms underlying carotenoid-microbiome interactions involve selective antimicrobial activity, bacterial carotenoid metabolism, modulation of host-derived factors, and synergistic effects with co-occurring bioactive compounds. Understanding these mechanisms creates opportunities for targeted dietary interventions and potentially novel therapeutic approaches for metabolic disease, inflammatory conditions, and age-related functional decline.

Future research should address several critical questions: What are the relative contributions of individual carotenoids versus synergistic effects of carotenoid mixtures in whole foods? How do baseline microbiome composition and host genetics influence responses to carotenoid consumption? Can microbiome profiling identify individuals most likely to benefit from increased carotenoid intake? What are the optimal doses, food sources, and preparation methods for maximizing microbiome benefits? Do carotenoid-induced microbiome shifts contribute significantly to the established disease-preventive effects of fruit and vegetable consumption?

Addressing these questions will require integrated approaches combining controlled dietary interventions, comprehensive microbiome profiling, metabolomic analyses, and clinical outcome assessment. As our understanding deepens, personalized nutrition recommendations based on individual microbiome profiles may enable optimized dietary strategies for preventing disease and promoting healthy aging. In the meantime, the existing evidence strongly supports consuming abundant and diverse carotenoid-rich plant foods as part of comprehensive dietary patterns that support gut microbiome health—advice that aligns perfectly with longstanding recommendations to increase fruit and vegetable consumption for optimal health.

References

Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., ... & Wang, J. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. *Cell Host & Microbe, 17*(5), 690-703.